We are live on
!
Find out more
WA
Wasatch Advisors Portfolio holdings
AUM
$15.3B
1-Year Est. Return
25.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.33%
1 Year Est. Return
+25.06%
3 Year Est. Return
+87.66%
5 Year Est. Return
+80.4%
10 Year Est. Return
+874.7%
AUM
$16.5B
AUM Growth
+$455M
(+2.8%)
Cap. Flow
-$513M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
23.61%
Holding
273
New
16
Increased
90
Reduced
147
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globant
GLOB
|
+$75.4M |
| 2 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$73.1M |
| 3 |
Certara
CERT
|
+$56.7M |
| 4 |
Shift4
FOUR
|
+$40.8M |
| 5 |
Fox Factory Holding Corp
FOXF
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABCM
Abcam PLC
ABCM
|
+$110M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$62M |
| 3 |
Medpace
MEDP
|
+$60.2M |
| 4 |
The Ensign Group
ENSG
|
+$53M |
| 5 |
Valvoline
VVV
|
+$52.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.67% |
| 2 | Healthcare | 18.3% |
| 3 | Consumer Discretionary | 16.93% |
| 4 | Industrials | 14.53% |
| 5 | Financials | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Gilead Sciences
GILD
$165B
| $3.16M | 0.02% |
40,950
| – | – |
|
227
Kimco Realty
KIM
$17.5B
| $3.15M | 0.02% |
159,655
+1,601
| +1% | +$30.2K |
|
228
iShares MSCI Taiwan ETF
EWT
$9.13B
| $3.12M | 0.02% |
66,425
| – | – |
|
229
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
| $2.98M | 0.02% |
+50,556
| New | +$3.02M |
|
230
Citigroup
C
$213B
| $2.96M | 0.02% |
64,382
-2,000
| -3% | -$93.7K |
|
231
Exagen
XGN
$105M
| $2.9M | 0.02% |
1,000,844
+283
| +0% | +$805 |
|
232
Noble Corp
NE
$6.54B
| $2.85M | 0.02% |
69,000
+2,000
| +3% | +$77K |
|
233
Roper Technologies
ROP
$40.4B
| $2.79M | 0.02% |
5,811
+564
| +11% | +$255K |
|
234
Toronto Dominion Bank
TD
$193B
| $2.73M | 0.02% |
44,000
+4,500
| +11% | +$271K |
|
235
ING
ING
$92.9B
| $2.69M | 0.02% |
200,000
-25,000
| -11% | -$319K |
|
236
iShares MSCI India Small-Cap ETF
SMIN
$750M
| $2.4M | 0.01% |
41,377
-164,732
| -80% | -$8.87M |
|
237
Eversource Energy
ES
$28.1B
| $2.15M | 0.01% |
+30,375
| New | +$2.26M |
|
238
HEICO Corp Class A
HEI.A
$36B
| $1.69M | 0.01% |
11,999
+1,875
| +19% | +$251K |
|
239
EOG Resources
EOG
$77.7B
| $1.66M | 0.01% |
14,548
-3,000
| -17% | -$343K |
|
240
Eaton
ETN
$141B
| $1.66M | 0.01% |
8,277
-5,000
| -38% | -$879K |
|
241
First Western Financial
MYFW
$306M
| $1.55M | 0.01% |
+83,204
| New | +$1.46M |
|
242
Amphenol
APH
$185B
| $1.32M | 0.01% |
31,172
+2,034
| +7% | +$79K |
|
243
Workday
WDAY
$41.5B
| $1.31M | 0.01% |
5,784
+327
| +6% | +$65.5K |
|
244
Biomerica
BMRA
$4.91M
| $1.3M | 0.01% |
119,158
-2,714
| -2% | -$32.1K |
|
245
Copart
CPRT
$28.5B
| $1.28M | 0.01% |
27,998
-4,636
| -14% | -$192K |
|
246
Cognex
CGNX
$9.62B
| $1.16M | 0.01% |
20,792
+577
| +3% | +$29.8K |
|
247
Old Dominion Freight Line
ODFL
$46.3B
| $1.08M | 0.01% |
5,824
+260
| +5% | +$42.1K |
|
|
AGIL
248
DELISTED
AgileThought Inc
AGIL
| $714K | ﹤0.01% |
951,843
-1,154,119
| -55% | -$1.53M |
|
249
Credicorp
BAP
$30.5B
| $686K | ﹤0.01% |
4,649
+221
| +5% | +$30.3K |
|
250
Clearwater Paper
CLW
$348M
| $649K | ﹤0.01% |
20,706
+3,634
| +21% | +$117K |
|
Similar funds
UM
RFC
MSV
IA
NMO
AT
Wasatch Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Wasatch Advisors held 273 positions worth $16.5B, up 2.8% from $16.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wasatch Advisors withdrew a net $513M in Q2 2023, closing 16 positions and reducing 147 holdings. Its most notable exit was Abcam PLC, an estimated $110M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Wasatch Advisors opened a new position in Certara worth $48.9M.
- Wasatch Advisors's largest Q2 2023 buy was Certara: 2,686,675 shares worth $48.9M.
- Wasatch Advisors added most to Globant in Q2 2023, an estimated $75.4M increase.
- Wasatch Advisors's biggest Q2 2023 reduction was Intra-Cellular Therapies Inc., cutting an estimated $62M.
- Wasatch Advisors fully exited Abcam PLC in Q2 2023, selling an estimated $110M.
- Wasatch Advisors's ten largest holdings make up 24% of its $16.5B portfolio in Q2 2023.
- Wasatch Advisors opened 16 new positions and closed 16 in Q2 2023.
- Wasatch Advisors's portfolio value rose 2.8% quarter-over-quarter to $16.5B.
Based on Wasatch Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.